Eurolab’s victory will provide financial relief to patients in South Africa, ensuring that Enzutix, a crucial treatment for prostate cancer, will remain accessible to South African patients at ...

Eurolab has achieved a landmark legal victory in South Africa, allowing the company to produce and sell a generic version of the prostate cancer medication enzalutamide, ensuring affordable access ...

They approached the court last year claiming that Eurolab's Enzutix, a generic treatment for prostate cancer, was identical to their Xtandi, which potentially infringed their patent. The drug is ...